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Abstract
Wound healing is a highly complex biological process composed of three overlapping
phases: inflammatory, proliferative, and remodeling. The acute inflammatory response
has being an integral role in tissue healing and fundamental for the homeostasis and
reestablishment. This phase depends on the interaction of cytokines, growth factors,
chemokines, and chemical mediators from cells to perform regulatory events and complex
interactions of the extracellular matrix, extracellular molecules, soluble mediators, various
resident cells such as fibroblasts and keratinocytes, and infiltrated leukocyte subtypes that
act to restore or replace the integrity of the skin. If this well-orchestrated response
becomes deregulated, the wound can become chronic or progressively fibrotic, with both
outcomes impairing tissue function, which can ultimately lead to organ failure and death.
In this chapter, we will review the pathway in the skin healing cascade, relating the major
chemical inflammatory mediators, cellular and molecular, as well as demonstrating the
local and systemic factors that interfere in healing and disorders associated with tissue
repair deficiency in chronic inflammations, burns and hypertrophy.
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1. Introduction
1.1. Skin wound healing
Skin is the largest organ of all vertebrates, and it is very important to protect the organism against
external damage [1]. When the loss of structural integrity of the skin occurs, the organism starts
the wound healing process, involving some coordinated, interdependent, and overlapping mech-
anisms—such as inflammation, cell proliferation, reepithelialization of wounded area, and extra-
cellular matrix remodeling—to restructure the skin homeostasis [2, 3]. The initial mechanism of
wound healing is the fibrin clot synthesis to avoid bleeding and to keep the local hemostasis,
leading to the platelet retention and activation of local vascular mediators [4, 5]. From now on,
there is the dilatation of the local vessels due to the release of histamine and serotonin, as well as
the increase of vessel permeability, improving the leukocyte migration to the wounded area and
starting the inflammatory process. In the first 5 days after the lesion, neutrophils are attracted to
the region, removing pathogenic antigens and dead tissue through phagocytosis and protease
secretion. After 3 days, there is the macrophage migration to the wounded area, with the mainte-
nance of inflammatory response [5]. Due to the tissue destruction, the local keratinocytes release
interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), essential cytokines in the inflamma-
tory mechanism, through recruitment and activation of leukocytes in the region and with impor-
tant roles coordinating other wound healing mechanisms. With these facts, keratinocytes,
macrophages, platelets, and endothelial cells of wounded area release some mediators such as
growth factors (EGF, FGF, PDGF, TGF-β), cytokines (IL-1β, IL-6, IL-8, IL-10, TNF-α, IFN-γ), and
chemokines, which will control other subsequent mechanisms in skin wound healing [6, 7].
Therefore, the inflammatory mechanism is an important step to the correct and well-coordinated
wound healing, modulating the subsequent mechanisms of healing. Furthermore, the compre-
hension of inflammatory response can lead to new treatments to wound repair and decrease of
healing disorders like hypertrophic scars, keloids, chronic inflammation, skin infections, and
unwounded lesions [8].
2. Materials and methods
The search for this chapter was carried out on PubMed, Scopus, andWeb of Science until June 2018,
using “inflammation”, “inflammatory process”, “skin wound healing”, “cytokines”, “chemokines”
Model Mediator Target/signaling protein Biologic effect References
In vivo
BALB/c mice
CD4 cells IL1β, IL-6, IL-17, IFN-γ,
and CXCL-1
IL-4
The absence of CD4 and
CD8 lymphocytes changes
in cytokine expression and
inflammatory cell infiltrate,
but does not influence
wound breaking strength,
collagen content, or
angiogenesis
Chen et al.
[50]
CD8 cells IL1β, IL-6, TNF-α, CXCL-1
and CCL-2, IL-4
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Model Mediator Target/signaling protein Biologic effect References
In vivo
BALB/c mice
Neutrophil MPO, macrophages, and
collagens
Neutrophil depletion
exhibited significantly
accelerated re-
epithelialization, without
altering the macrophage
infiltration or the collagen
content in the wound bed
Dovi et al.
[51]
In vivo
C57BL/6 mice
Epinephrine IL-6, IL-1β, TNF-α, IL-1α,
and GM-CSF and PMN
Epinephrine altered the
neutrophil (PMN)-
dependent inflammatory
response to a cutaneous
wound through an IL-6
mediated mechanism via
β2 adrenergic receptor-
dependent
Kim et al.
[52]
In vivo
C57Bl/wild-type
mice
IL-1β Human recombinant IL-1β,
occludin, claudin-1,
claudin2, claudin-3, and
claudin-5
IL -1β induced increased
claudin -1 expression in cell
culture
Rozlomiy
and
Markov
[53]
In vivo
BALB/C mice
IL-12 Recombinant murine IL-
12-rMuIL-12/collagen
structure and alignment
IL-12 induced a rapid onset
and higher metabolic
activity in wounded skin at
early time
Li et al. [54]
In vivo
BALB/C mice
EFG EGFR/vaccination
extracellular domain
(ECD)
Not change the wound
healing and inflammatory
speed
Fuentes
et al. [55]
In vivo
BALB/C mice and
IL-6 KO mice
IL-6 IL-6/ICAM-1
VCAM-1
IL-1α
Il-1β
MIP-1α
Delayed angiogenesis and
collagen deposition, by the
reduced expression of
angiogenic and fibrogenic
growth factors
Reduced inflammatory
response
Lin et al.
[56]
In vitro
Keratinocytes
IL-1β and TGF-β1 IL-1β TGF-β1/tissue type
plasminogen activator
(tPa)
IL-1 β interacts com PA by
tPA
TGF-β1inibits functional
tPA
Lian et al.
[57]
In vitro
Human and mice
fibroblasts
Platelet-derived growth
factor (PDGF)
IL-8 Fetal fibroblasts produced
less IL-8. Much less IL-8 in
stimulated fetal fibroblasts
than in adults
Liechty
et al. [58]
In vivo
C57/Bl6 mice and
Mgl2DTR/GFP mice
CD301b macrophage IL-10, platelet-derived
growth factor–β and TGF-
β1
CD301b-expressing
subpopulation of
macrophages is critical for
activation of reparative
process
Shook et al.
[59]
In vivo
Levels and role of
chemokine CX3CL1
(fractalkine) and its
receptor CX3CR1 in
mouse model
CX3CL1 and CX3CR1 MPO, Hydroxyproline
(collagen accumulation at
the wound sites), TGF-1,
VEGF
Inflammation, fibrosis,
neovascularization, and
regeneration of
parenchymal cells were
affected by the receptor
Ishida et al.
[31]
Regulatory Mechanisms and Chemical Signaling of Mediators Involved in the Inflammatory Phase of Cutaneous…
http://dx.doi.org/10.5772/intechopen.81731
7
Model Mediator Target/signaling protein Biologic effect References
In vivo
db/db mice as a
diabetic skin wound
model.
Peptide inhibitor of
complement C1 (PIC1)
complement system (CS),
Signal transducer, activator
of transcription 4 (STAT4),
Leukocyte infiltration, C5a,
C3, C3a
PIC1 loaded into the derma
CELL did reduce the
number of inflammatory
cells in the wound bed
Cunnion
et al. [60]
In vivo kCYC/mice IL-10 Mast cells migrating,
Macrophages, IL-10, IL-6,
aFGF, bFGF, TGF-1, PDGF,
TNF-αmRNA
kCYC/mice mast cell
increased.
IL-10: increased, bFGF
decreased in kCYC/mice.
IL-10 plays an important
role in delayed wound
healing
Kimura
et al. [61]
In vivo
C57BL/6J mice
IL-1β p38, MAPK, ERK IL-1β stimulates PTGS2 in
fibroblast and p38-MAPK
in other cells. PGE2
activates INHBA
Arai et al.
[62]
In vivo
Sprague Dawley
Rats
IL-4, IL-12, IL-6, IGF-1
and IFN-α e γ
— IGF-1, IL-4, IL-6, and IL-3
important in inflammatory
phase
Lania et al.
[63]
In vivo
Mouse model with
conditional
depletion of
macrophages
Inducible diphtheria
toxin receptor +
diphtheria toxin
injections + mice lacking
the TGF-b receptor type
II (TbRII), Depletion of
macrophages
Number of macrophages,
neutrophils, and cells
positive for activated
caspase-3, VEGF-A, or
TGF-β1
Inflammatory phase:
reduced formation of
vascularized granulation
tissue, leading to
minimized scar formation.
Phase of tissue formation:
severe hemorrhage in the
wound. Wound closure did
not occur.
No significant impact in
tissue maturation phases.
Lucas et al.
[64]
In vivo
C57Bl/6J mice
Ly6cloMHCIIhi
macrophage
IL-17 Ly6cloMHCIIhi
macrophages had a non-
inflammatory
transcriptomic profile
and demonstrated that
inhibition of IL-17 in
mice accelerated
normal and delayed
healing.
Rodero
et al. [65]
In vivo
C57BL/6mice
γδ T Cell FGF-7, FGF-10, IGF-1,
JAML
γδT Lymphocytes
stimulate the gene and
protein expression of
important mediators in
acute healing model
Xu et al.
[66]
Mutant mice ICOS
/
ICOSL -?-
IL-6 and IL-4 — IL6 and ICOS-ICOSL
signaling the skin wound
healing in mutant mice
Maeda
et al. [67]
In vivo
C57BL/6 mice and
human acute
wounds
Macrophage M1 and M2 IRF-8 IRF-8 is an inflammatory
mediator.
Inhibition of IRF-8 impairs
wound healing.
Guo et al.
[68]
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Model Mediator Target/signaling protein Biologic effect References
IRF8 coordinates M1
macrophage population
(decrease of M1 mediators
IL-1 β, IL-6, TNF-α, iNOS),
with no interference in M2
macrophage mediators
(arg-1, mrc-1, IL-10)
In vitro
Human skin
fibroblasts CCD966-
SK and HaCaT
keratinocytes
In vivo
BALB/C mice
Fibroblasts and
keratinocytes IL-19
IL-19 IL-19 upregulates KGF
expression in fibroblasts
and KGF induces IL-19
expression in keratinocytes
KGF promotes
keratinocyte proliferation.
IL-19 induces keratinocyte
migration
Sun et al.
[69]
In vivo
SKH-1 mice
COX-2 COX-1 and COX-2 Selective inhibition of
COX-2 and nonselective
inhibition of COX-1 and
COX-2 did not affect the
healing of sutured surgical
incisions in mouse skin.
Blomme
et al. [70]
In vivo
BALB/c mice
IFN-γ and TGF-β1 MPO, TGF-β, Stat1, P-
Stat1, Smad2, P-Smad2,
Smad3, Smad7, α-Tubulin,
VEGF, CD3, IL-12p35, IL-
12p40, IL-18, COLIAI
Crosstalk between the IFN-
γ/Stat1 and TGF-β1/Smad
signaling pathways in the
skin wound healing.
Ishida et al.
[71]
In vivo
Wistar rats
— EGF, VEGF, IGF and FGF Growth factors accelerated
the healing process
promoting greater
angiogenic activity and
accelerated fibroplasia and
the deposition of type I
collagen
de Masi
et al. [72]
In vivo
C3H/Hej TLR4-
deficient and wild-
type C3H/HeOuj
mice
In vitro
NHEK and THP1
cell line
TLR4 CD3+, T cells, Ki67, NF-κB,
p-p38, and p-JNK
TLR4 is activated in early
skin wound healing, with a
functional mutation of
TLR4 results in altered
inflammatory cell
infiltration, differential
cytokine production, and
impaired wound closure,
besides IL-1β production
by injured keratinocytes is
induced through the TLR4-
p38/JNK pathway
Chen et al.
[73]
In vivo
C57BL/6 mice
Vγ4 T cells IL-17A, IGF-1, CCL20, NF-
κB p65, p-NF-κB p6,
STAT3, p-STAT3, IL-1β, IL-
23p19
Mechanistic link between
Vγ4 T cell-derived IL-17A,
epidermal IL-1β/IL-23,
DETC-derived IGF-1, and
wound healing responses
in the skin
Li et al. [74]
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Model Mediator Target/signaling protein Biologic effect References
In vitro
Primary
keratinocytes and
fibroblasts of IL-6
KO or C57BL/6 mice
IL-6 from keratinocytes
and fibroblasts
IL-6, STAT3 IL-6 induces keratinocyte
migration indirectly,
through the STAT3
activation cascade in
fibroblasts, with the
synthesis of a fibroblast-
derived factor
Gallucci
et al. [75]
In vivo
Ja18KO (iNKT cell-
deficient) mice and
C57BL/6 mice
Invariant natural killer T
cells (iNKT) and
neutrophils
MIP-2, KC, IL-17A, MCP-1,
RANTES
MIP-2, KC, IL-17A
(neutrophil attractors)
were increased in JA18KO
mice. MCP-1 and RANTES
(macrophage and
lymphocyte attractors)
were decreased in Ja18KO
mice.
Decrease of neutrophil
apoptosis in Ja18KO mice.
iNKT ciNKT cells promote
skin wound healing by
regulating neutrophil
apoptosis
Tanno et al.
[76]
In vivo
PPAR-γ KO mice
and C57BL/6 J male
mice
PPAR-γ from
macrophages
PPAR-γ, TNF-α, VEGF,
collagen 1
Increase of TNF-α in
PPAR-γ KO mice and
delay in wound healing
Chen et al.
[77]
In vivo
Human incision
model
IL-4 from mast cells IL-4, MCP-1 Increased MCP-1
chemoattractant activity in
mast cell migration.
Increase of IL-4 synthesis
by mast cells
IL-4 stimulates fibroblast
activation
Trautmann
et al. [78]
In vivo
WBB6F1/J-KitW/
KitW–v mast cell KO
female mice and
WBB6F1 female
mice
Mast cells TNF-α, MIP-2, VEGF,
FGF-2
Decrease of neutrophil
infiltration in KO mice.
Increase of FGF-2 in KO
mice.
Mast cells modulate
neutrophil infiltration in
wound site, with unlikely
influence in proliferative
phase of wound healing
Egozi et al.
[79]
In vivo
miR-31 loss-of-
function mice
miR-31 NF-kB, STAT3, RAS/
MAPK
Increase of miR-31 in
wound edge keratinocytes
during inflammation
through NF-kB and STAT3
pathways
miR-31 regulates
keratinocyte migration
through RAS/MAPK
pathway
Shi et al.
[80]
In vitro
Primary normal
human
IL-6, IL-8, TNF-α STAT3, p38, JNK, EGFR STAT3, p38, JNK, and NF-
kB activation lead to IL-6,
IL-8, and TNF-a increase in
Han et al.
[81]
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and “growth factors” as keywords. The articles published in the last 20 years were considered
(1998–2018). The results are displayed in Table 1.
3. Results and discussion
3.1. Mediators involved in the inflammatory phase of wound healing
Wound healing is an extremely dynamic and interactive biological process involving complex
interactions of extracellular matrix, extracellular molecules, soluble mediators, multiple resi-
dent cells (fibroblasts and keratinocytes), and subtypes of infiltrating leukocytes that together
act to restore integrity of the damaged tissue and replace the lost. This process comprises three
sequential and overlapping stages, regardless of the amount of injured tissue: hemostasis/
inflammation; cell proliferation and matrix repair; and reepithelialization and remodeling of
scar tissue, which involve complex biochemical and cellular mechanisms [9].
The inflammatory phase, hemostasis, leukocyte migration, and the beginning of the tissue
repair cascade occur. Initially, in response to inflammatory agents, there is reduction of blood
flow by vasoconstriction, and with extravasation of blood from the injured vessel, platelets are
activated causing the coagulation process to begin [10]. During this process, there is a progres-
sive increase in vascular permeability to migrant cells and biologically active substances. From
this process, essential elements for the physiological continuation of healing appear: a fibrin
framework, necessary for the migration of the cells that will reach the lesion site, and pro and
anti-inflammatory chemo/cytokines that will aid in cell activation and migration [11].
3.2. Neutrophils and macrophages
Neutrophils are the first immune cells recruited into wounded tissue to play a role in
reestablishing tissue homeostasis through pathogen phagocytosis and macrophage recruit-
ment as well as excessive neutrophil activity which can contribute to the development of
Model Mediator Target/signaling protein Biologic effect References
keratinocytes
In vivo
BALB/c female mice
infected wounds.
Mixidin2 and mixidin3
modulated inflammatory
signaling with anti-
inflammatory activity
In vivo
B57BL6/J, B57BL6/
NJ, CD301bGFP-
DTR, and Il27Ra/
mice
IL-27 (dendritic cells) Keratin-6 (keratinocytes) IL-27 is synthesized by
dendritic cells and
modulates keratinocyte
proliferation, migration,
and differentiation after
skin injury
Yang et al.
[82]
Table 1. Chemical mediators involved in the inflammatory response of skin wound healing.
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nonhealing wounds. They play a central role in both killing microbes and promoting wound
healing [12]. These cells are extremely important in the inflammatory process, but once
recruited into wound sites in such large numbers with exacerbated cytokine secretion,
overproduction of reactive oxygen species (ROS), causing extracellular matrix (ECM) and cell
membrane damage, and resulting in premature cell senescence [13].
Monocyte-derived macrophages are often considered to be the most important immune cell
type in this process. In intact skin, these cells are the most abundant cell types performing
sentinel and homeostatic function. The monocytes migrate from vascular circulation to wound.
Both infiltrating and resident macrophages on skin are activated by local signals and devel-
oped into several subpopulations defined by their different functional phenotypes [14]. Many
studies have confirmed that macrophages are critical for proper skin wound healing [15–17].
Upon initial infiltration, proinflammatory macrophages, also called M1, are also responsible
for removing cellular debris, damaged matrix, microbes, and neutrophils [17].
3.3. Cytokines
Wound healing is regulated by growth factors and cytokines that are essential not only in the
inflammatory process but also in the cell proliferation and maintenance in the repair process
by various mechanisms [18].
Cytokines released by neutrophils during apoptosis are chemotactic for monocytes, which
start to arrive 5–6 h post injury. IL-1β is a key interleukin of antimicrobial response by
inflammatory response amplification; it stimulates leukocyte recruitment, the release of acute
phase proteins, and the increase of permeability of blood vessels [19]. Some authors consider
this cytokine as part of a proinflammatory positive feedback loop that sustains a persistent
proinflammatory wound macrophage phenotype, contributing to impaired healing of diabetic
wounds [18].
TNF-α is a second proinflammatory cytokine that contributes to a chronic wound state. It acts
on several stages of leukocyte recruitment mechanism, neutrophils and macrophages, induc-
ing molecular adhesion regulation, chemokine production, and metalloproteinase matrix, as
well as tissue inhibitors of metalloproteinases [20]. Interleukin IL-6 is a soluble proinflam-
matory mediator with pleiotropic activities in inflammation, hematopoiesis, and immune
responses [21]. Together with TNF-α and IL-1β, IL-6 is present in high concentrations in
inflammatory processes. After IL-6 is secreted into the area of injury at the beginning of the
inflammatory process, it is directed to the liver through the bloodstream, transmitting the
information and inducing the hepatocytes to produce certain inflammatory agents [22].
Another important cytokine in the inflammatory phase is IL-8, which also acts as a chemokine
(CXCL8). This cytokine is mainly produced by monocytes and in smaller amounts by fibro-
blasts, endothelial cells, keratinocytes, melanocytes, hepatocytes, and chondrocytes. It usually
receives stimuli from other cytokines, such as IL-1, TNF-α, and IFN-γ [23]. The main action of
IL-8 is the migration to cells of the immune system, mainly neutrophils, also determining an
increase in the expression of endothelial adhesion molecules cells [13].
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Since prolonged presence of proinflammatory cytokines may prevent resolution and both pro
and anti-inflammatory cytokines are necessary for wound healing, sequential delivery of
pro and anti-inflammatory cytokines could be an interesting strategy for improving chronic
wound healing [17]. For example, IL-22, considered a proinflammatory cytokine, helped
the wound healing of diabetic mice by inducing keratinocyte proliferator and signal transduc-
tion and activation of transcription 3 (STAT3) [24]. In this same context but in other tissues, to
improve bone repair, decellularized bone was engineered to sequentially release IL-4
(proinflammatory cytokine) and implanted in mice at the site of injury. The sequential release
promoted macrophage polarization to switch from a pro to an anti-inflammatory phenotype,
resulting in improved wound healing [25].
IL-10 is a regulatory cytokine, which can be secreted by many kinds of immune cells, including
Th1, Th2, Th17, Treg, and CD8+ T cells, B cells, dendritic cells, macrophages, NK cells, eosino-
phils, neutrophils, basophils, and MCs, as well as nonimmune cells including keratinocytes.
This cytokine is considered an anti-inflammatory cytokine because it is capable of inhibiting
the production of other proinflammatory cytokines, such as TNF-α, IL-1β, and IL-6 [26]. In
addition to its potent anti-inflammatory effects, IL-10 has been shown to regulate fibrogenic
cytokines, such as transforming growth factor-β (TGF-β), as a part of its role in the regulation
of tissue remodeling [27].
3.4. Chemokines
Chemokines are small molecules that induce chemotaxis and activation of certain subsets of
leukocytes. They are classified into four types: CC chemokines, CXC chemokines, C chemokines,
and CX3C chemokine. Chemokines play important roles in wound healing and are important for
maintaining skin homeostasis, and their disruption can result in skin pathologies [28]. They also
play important roles in establishing microenvironment in which migratory immune cells,
together with skin-resident cells, cause prolonged inflammation [29].
CX3CL1 is expressed by inflamed endothelial cells and epithelial cells, including macrophage,
keratinocytes, and vascular smooth muscle cells, whereas CX3CR1 is mainly expressed by
neutrophils, monocytes, mast cells, T cells, and NK cells [30]. In the cutaneous wound healing,
CX3CL1 has been shown to be expressed by macrophages and endothelial cells, while CX3CR1
is expressed by macrophages and fibroblasts. Decreased expression of macrophage-related
cytokines, such as TGF-β and VEGF, and reduced deposition and α-smooth muscle actin and
collagen were shown in the injured skin of CX3CR1/mice [31].
3.5. Growth factors
Growth factors are naturally occurring endogenous mediators capable of controlling the con-
trol of cell growth, proliferation, migration, and differentiation [32]. Once bound specifically to
its receptor, the ligand-receptor interaction is able to activate intracellular signal transduction
pathways that regulate different cellular functions [33].
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PDGF plays a crucial role in the healing process in both chronic and normal wounds. This
growth factor is released from degranulating platelets following an injury into the wound fluid
[34]. PDGF stimulates mitogenicity and chemotaxis of cells, such as neutrophils, macrophages,
fibroblasts, and smooth muscle cells to the site of the wound, initiating the inflammatory process
stage [35]. Its function has already been described during the stage of epithelialization of wound
healing by upregulating the production of growth factors, such as insulin-like growth factor
(IGF)-1 and thrombospondin-1, in turn IGF-1 increases the motility of keratinocyte cells and
thrombospondin-1 inhibits proteolytic and enzymatic degradation of PDGF [36].
Angiogenesis is an extremely important process in normal development and tissue homeosta-
sis and repair, besides contributes directly also to various forms of pathology, such as tumor
development and metastasis, psoriasis, rheumatoid arthritis, and wet macular degeneration
[37]. One of the most important proangiogenic mediators is vascular endothelial growth factor
(VEGF), responsible for stimulating new blood vessels formation, tissue proliferation, migra-
tion, differentiation, and survival, which contribute to the angiogenesis process, in addition to
influencing the repair and wound closure and granulation tissue formation [38]. The VEGF
family has several members, and one of its members such as VEGF-A begins the process of
wound healing promoting biological events linked to angiogenesis and migration of endothe-
lial cells [39]. Administration of VEGF-A has been reported to restore impairment of angiogen-
esis in diabetic ischemic limbs in an animal model as well as to improve the reepithelialization
process of diabetic wounds [40].
Epidermal growth factor (EGF) stimulates proliferation and differentiation of various cells,
including fibroblasts, endothelial cells, and epithelial cells, and shows mitogenic and migra-
tory activity on the edge keratinocytes of the lesions [41]. EGF participates in this mechanism,
which is considered essential in the cutaneous wound healing, which begins a few hours after
the injury, but presents a more evident activity in the proliferative phase of wound healing,
and continues until the extracellular matrix remodeling phase [42].
Another growth factor that involves healing process activity is the family of fibroblast growth
factors (FGF), which have already been reported to play crucial events in the wound healing
process [43]. FGFs are secreted by keratinocytes, fibroblasts, endothelial cells, smooth muscle
cells, chondrocytes, and mast cells [44]. During an acute cutaneous wound process, it has been
reported an increase in the production of FGF-2 and that they are responsible for formation of
granulation tissue, reepithelialization, and tissue remodeling [45]. Moreover, functions such as
synthesis, deposition of various constituents of the extracellular matrix, and increased motility
of keratinocytes are regulated by FGF-2 [46].
Transforming growth factor type-β (TGF-β) activity in the healing process was analyzed by
being one of the proteins with the greatest spectrum of activities, with effect on cell prolifera-
tion, differentiation and production of extracellular matrix, and immunological modulation
[46, 47]. Moreover, TGF-β has many biological activities and is thought to be a particularly
important contributor to fibrosis, angiogenesis, and tissue repair. This growth factor can also
influence T cells, including Th17 and Treg cells, as well as B cells, dendritic cells, NK cells,
neutrophils, and eosinophils [48, 49].
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4. Conclusion
Increasing scientific knowledge has contributed to define highly coordinated molecular and
cellular events involved in the cutaneous wound healing. Recent findings show that there is a
clear correlation between the stage of the wound and its effectiveness in the healing process,
and endogenous mediators, such as cytokines, chemokines, and growth factors, indicate
important and crucial steps in the normal healing and are useful as prognostic indicators.
Although much is known about the cellular and molecular basis of normal skin healing, there
are still avenues of research left to unravel that will guide us to better therapies, new thera-
peutic targets, and strategies for the skin wound treatment, especially chronic wounds.
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